Flowers Foods Inc: Form 10-K for the period ended Dec 30, 2023
Filed with the SEC on Feb 21, 2024 and accepted by EDGAR at Feb 21, 2024, 16:03 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-30 | $5.09bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 12 months2023-01-01 to 2023-12-30 | $5.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2023-01-01 to 2023-12-30 | $2.12bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2023-01-01 to 2023-12-30 | $172.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2023-01-01 to 2023-12-30 | $36.6m | us-gaap:InterestExpense |
| Income tax | 12 months2023-01-01 to 2023-12-30 | $33.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2023-01-01 to 2023-12-30 | $123.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-30 | $0.58 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-01-01 to 2023-12-30 | $0.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-30 | 213,356,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-30 | $349.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-30 | $129.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2023-01-01 to 2023-12-30 | $195.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2023-01-01 to 2023-12-30 | $45.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-30 | $22.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-30 | $687.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-30 | $3.43bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-30 | $659.2m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2023-12-30 | $1.05bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2023-12-30 | $1.35bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-017647. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.